Introducing the 2024 OHC Rare Disease Scholar Awards
The Oxford-Harrington Rare Disease Centre (OHC) has proudly announced its inaugural class of Scholar Award recipients, marking a significant leap forward in the quest to address the challenges posed by rare diseases. This initiative represents a critical intersection of academic research and clinical practice aimed at transforming groundbreaking discoveries into effective treatments for patients worldwide.
Commitment to Rare Disease Research
With strong foundations laid through partnerships between the esteemed University of Oxford and the Harrington Discovery Institute, the OHC is at the forefront of rare disease research. In its first year, the program received numerous exceptional proposals from institutions across North America and the UK, showcasing the vast talent and creativity present in the scientific community. Each selected Scholar exemplifies a commitment to addressing some of the most challenging health conditions that affect many.
Financial Support and Resources
Each of the ten awarded scholars will receive funding of £100,000 to support their research endeavors. This financial backing is supplemented by personalized guidance in therapeutics development, ensuring that scholars have the necessary resources to advance their projects effectively. In addition to the initial funding, scholars may access acceleration and investment opportunities, with potential funding of up to £1,000,000 based on specific research project milestones.
Celebrating Innovation in Science
Dr. Matthew Wood, the Director and Chief Scientific Officer at OHC, expressed enthusiasm regarding the caliber of talent that applied for the Scholar Awards. He emphasized how the diversity and quality of research proposals made the selection process particularly challenging yet rewarding. Each project displays unique innovation, creativity, and the promise for real clinical impact, proving that academic research has the power to transform lives.
Highlighting the Award Recipients
The 2024 OHC Rare Disease Scholar Award recipients represent a diverse array of fields and institutions, including:
Jacquelyn Bower, PhD – University of North Carolina at Chapel Hill, USA
Focus: Novel viral gene therapy for rare eye tumors
Louis Chesler, MD, PhD – Institute of Cancer Research, UK
Focus: Regulated cell therapies for brain cancers
Charles Gersbach, PhD – Duke University, USA
Focus: Reprogramming immune cells for Hodgkin's lymphoma
Xianxin Hua, MD, PhD – University of Pennsylvania, USA
Focus: New cellular approaches for treating acute myeloid leukemia
Michele Jacob, PhD – Tufts University School of Medicine, USA
Focus: Drug development for CTNNB1 defect-related brain abnormalities
Bowen Li, PhD – University of Toronto, Canada
Focus: Nucleic acid therapy for cystic fibrosis
Michael Pacold, MD, PhD – New York University, USA
Focus: Drugs for restoring brain function in metabolic diseases
Carlo Rinaldi, MA, MD, PhD – University of Oxford, UK
Focus: Nucleic acid therapy for spinal muscular atrophy
Timothy Yu, MD, PhD – Boston Children's Hospital, USA
Focus: DNA-based therapy for PEX1 Zellweger Syndrome
Haiyan Zhou, MD, PhD – University College London, UK
Focus: Nucleic acid therapy for rare mutations causing paralysis
Future Call for Proposals
The OHC invites interested researchers to prepare their proposals, as the next funding call for the Oxford-Harrington Rare Disease Scholar Award will open soon. This avenue provides an excellent opportunity for academics seeking to contribute to the development of therapeutic solutions for rare diseases. Engaging with the OHC can connect more minds and resources to drive innovation and success in this vital area of medicine.
Frequently Asked Questions
What is the Oxford-Harrington Rare Disease Centre?
The Oxford-Harrington Rare Disease Centre is a collaboration between the University of Oxford and the Harrington Discovery Institute, focused on accelerating research and development in the field of rare diseases.
What is the purpose of the OHC Scholar Awards?
The OHC Scholar Awards aim to support researchers who are working on breakthrough treatments for rare diseases by providing funding and expert guidance in therapeutics development.
How much funding do scholars receive from the OHC?
Each scholar awarded the OHC Rare Disease Scholar Award receives £100,000 and may also access additional funding based on their project milestones.
When will the next funding call open for proposals?
The next funding call for the Oxford-Harrington Rare Disease Scholar Award will open on the 15th of January, 2025.
Who can apply for the OHC Scholar Awards?
The OHC Scholar Awards are open to researchers affiliated with institutions that are focused on rare disease research across North America and the UK.
